AI Article Synopsis
- Alagille syndrome is an autosomal dominant disorder characterized by a lack of intrahepatic bile ducts, leading to symptoms like chronic cholestasis and xanthomas, along with potential heart, skeletal, and other organ issues.
- Most cases are linked to mutations in the JAG1 gene, with a diagnosis made through genetic testing; the condition occurs in roughly 1 in 30,000 to 50,000 individuals.
- Treatment varies based on symptoms, and severe cases may require liver transplantation; a specific case highlighted includes main bile duct hypoplasia, cholestasis, and associated kidney and vertebral abnormalities.
Article Abstract
Alagille syndrome is an autosomal dominant and multisystemic disease that generally manifests itself with intrahepatic bile ducts paucity, chronic cholestasis, xanthomas and with other less frequent clinical manifestations such as congenital heart disease, skeletal abnomalies, ophthalmic, vascular, renal and growth failure. Symptoms can be subclinical or very severe. Is caused by various genetic mutations and the majority of patients have a detectable mutation in JAG1 (90%), the remainder have mutations in NOTCH2. The diagnosis is molecular and the incidence is approximately 1 in 30,000 - 50.000. Patient management can be very complex and treatment depends on the district affected and on the symptoms. In more serious cases, with terminal liver disease, liver transplantation is used. We describe a case with main bile duct hypoplasia, intrahepatic bile ducts paucity, cholestasis and gallbladder dimorphism associated with renal malrotation and butterfly vertebrae.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11298873 | PMC |
| http://dx.doi.org/10.1016/j.radcr.2024.06.031 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!